Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement
and fatal systemic infection. WHO has classified the disease as emerging and uncontrolled
and estimates that the infection results in two million new cases a year. There are 12 million
people currently infected worldwide, and leishmaniasis threatens 350 million people in 88
countries. Current treatment is based on chemotherapy, which relies on a handful of drugs
with serious limitations such as high cost, toxicity, difficult route of administration and lack of …